- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 13, 2026 | 4.66M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 1.69M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 25.84K sh |
| Capex | Q1 2026 · Mar 31, 2026 | $5K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$2.58M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$537K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $375K |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $1.78M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$28.2M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$26.66M |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | −$121.92M |
| Stockholders Equity restated | Q1 2026 · Dec 31, 2024 | −$119.21M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $29.02M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $22.26M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $29.06M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $30.43M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $662K |
| Current Assets | Q1 2026 · Dec 31, 2025 | $3.76M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $862K |
| Total Assets | Q1 2026 · Dec 31, 2025 | $3.78M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$2.05 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$105.09 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$2.05 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$105.09 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $2.86M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $990K |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $1.15M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $434K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$3.46M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$2.72M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$4.01M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$1.42M |